皖南医学院学报
皖南醫學院學報
환남의학원학보
ACTA ACADEMIAE MEDICINAE WANNAN
2014年
5期
402-404,408
,共4页
石少凤%田德明%黄文斌%怀建国%王劲松
石少鳳%田德明%黃文斌%懷建國%王勁鬆
석소봉%전덕명%황문빈%부건국%왕경송
卵巢癌%人附睾分泌蛋白4%免疫组织化学%生物标志物
卵巢癌%人附睪分泌蛋白4%免疫組織化學%生物標誌物
란소암%인부고분비단백4%면역조직화학%생물표지물
ovarian cancer%human epididymis protein-4%immunohistochemistry%biomarker
目的:研究人附睾分泌蛋白4( HE4)在卵巢良性、交界性和恶性上皮性肿瘤的表达,探讨HE4在卵巢癌发生发展及诊断中的作用。方法:应用免疫组化EnVision法检测20例卵巢良性上皮性肿瘤、15例交界性肿瘤和55例恶性上皮性肿瘤中HE4表达。结果:HE4在卵巢良性、交界性和恶性上皮性肿瘤中的阳性表达率分别为15.5%、53.3%和83.6%,HE4在卵巢恶性上皮性肿瘤中的表达明显高于卵巢交界性和良性上皮性肿瘤,差异有统计学意义(P<0.05,P<0.01)。随着临床分期增高,HE4蛋白阳性表达率亦逐渐增高,但无统计学意义( P>0.05);HE4蛋白表达与卵巢癌淋巴结转移无相关性( P>0.05)。HE4主要在卵巢浆液性肿瘤和子宫内膜样癌中表达。结论:HE4在卵巢恶性上皮性肿瘤中高表达提示其可能作为诊断卵巢癌的一种标记物,且肿瘤组织学类型可能为浆液性肿瘤和子宫内膜样癌。
目的:研究人附睪分泌蛋白4( HE4)在卵巢良性、交界性和噁性上皮性腫瘤的錶達,探討HE4在卵巢癌髮生髮展及診斷中的作用。方法:應用免疫組化EnVision法檢測20例卵巢良性上皮性腫瘤、15例交界性腫瘤和55例噁性上皮性腫瘤中HE4錶達。結果:HE4在卵巢良性、交界性和噁性上皮性腫瘤中的暘性錶達率分彆為15.5%、53.3%和83.6%,HE4在卵巢噁性上皮性腫瘤中的錶達明顯高于卵巢交界性和良性上皮性腫瘤,差異有統計學意義(P<0.05,P<0.01)。隨著臨床分期增高,HE4蛋白暘性錶達率亦逐漸增高,但無統計學意義( P>0.05);HE4蛋白錶達與卵巢癌淋巴結轉移無相關性( P>0.05)。HE4主要在卵巢漿液性腫瘤和子宮內膜樣癌中錶達。結論:HE4在卵巢噁性上皮性腫瘤中高錶達提示其可能作為診斷卵巢癌的一種標記物,且腫瘤組織學類型可能為漿液性腫瘤和子宮內膜樣癌。
목적:연구인부고분비단백4( HE4)재란소량성、교계성화악성상피성종류적표체,탐토HE4재란소암발생발전급진단중적작용。방법:응용면역조화EnVision법검측20례란소량성상피성종류、15례교계성종류화55례악성상피성종류중HE4표체。결과:HE4재란소량성、교계성화악성상피성종류중적양성표체솔분별위15.5%、53.3%화83.6%,HE4재란소악성상피성종류중적표체명현고우란소교계성화량성상피성종류,차이유통계학의의(P<0.05,P<0.01)。수착림상분기증고,HE4단백양성표체솔역축점증고,단무통계학의의( P>0.05);HE4단백표체여란소암림파결전이무상관성( P>0.05)。HE4주요재란소장액성종류화자궁내막양암중표체。결론:HE4재란소악성상피성종류중고표체제시기가능작위진단란소암적일충표기물,차종류조직학류형가능위장액성종류화자궁내막양암。
Objective:To investigate the expression of human epididymis protein 4 (HE4) in benign,borderline and malignant epithelial tumor of ovary, and its role in the carcinogenesis and progression as well as diagnosis of ovarian cancer.Methods:Immunohistochemical EnVision technique was used to detect the expression of HE4 in 20 cases of benign tumor,15 borderline tumor and 55 malignancies.Results:HE4 was positively expressed in 15.5% of benign tumors,53.3% in borderline and 83.6% in malignancies,respectively.HE4 expression was higher in ovarian malignant epithelial tumor than in borderline and benign epithelial cases,which suggested statistical difference(P<0.05,P<0.01).Although HE4 expression was increased with advanced clinical stage,yet it had no statistical significance and no correlation with lymph node metastasis (P>0.05).Expression of HE4 was predominantly seen in serous tumor and endometrioid adenocarcinoma .Conclusion:High expression of HE4 in ovarian cancer can be a novel biomarker for diagnosis of ovarian malignant epithelial cancer,this histological marker may be suggestive of serous tumor and endometrioid adenocarcinoma .